LeukoTrap SOLX A Additive (Haemonetics Manufacturing Inc)


Welcome to the PulseAid listing for the LeukoTrap SOLX A Additive drug offered from Haemonetics Manufacturing Inc. This Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Haemonetics Manufacturing Inc
NON-PROPRIETARY NAME: AS-7 A Additive Solution
SUBSTANCE NAME: ADENINE; MANNITOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-11-12
END MARKETING DATE: 0000-00-00


LeukoTrap SOLX A Additive HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLeukoTrap SOLX A Additive from Haemonetics Manufacturing Inc
LABELER NAME: Haemonetics Manufacturing Inc
DEA SCHEDULE:
ACTIVE STRENGTH: .03; 1.1(g/80mL; g/80mL)
START MARKETING DATE: 2015-11-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53157-002_eab5a1f9-bed2-4a42-9544-d5912cd267b8
PRODUCT NDC: 53157-002
APPLICATION NUMBER: NDA110059

Other ADENINE; MANNITOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Haemonetics Manufacturing IncLeukoTrap SOLX A Additive